Market Momentum Report: Biocryst Pharmaceuticals Inc. (BCRX)’s Negative Close at 6.45

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $6.45 in the last session, down -1.53% from day before closing price of $6.55. In other words, the price has decreased by -$1.53 from its previous closing price. On the day, 1.37 million shares were traded. BCRX stock price reached its highest trading level at $6.75 during the session, while it also had its lowest trading level at $6.41.


We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.48 and its Current Ratio is at 3.73.

On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.

Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 24 ’24 when McKee Amy E sold 8,600 shares for $6.32 per share. The transaction valued at 54,352 led to the insider holds 27,831 shares of the business.

SANDERS MACHELLE sold 4,689 shares of BCRX for $28,134 on Jun 17 ’24. The Director now owns 27,742 shares after completing the transaction at $6.00 per share. On Jun 14 ’24, another insider, HEGGIE THERESA, who serves as the Director of the company, sold 6,698 shares for $6.11 each. As a result, the insider received 40,925 and left with 52,852 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1322876544 and an Enterprise Value of 1839223168. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.75. Its current Enterprise Value per Revenue stands at 5.175 whereas that against EBITDA is -22.406.

Stock Price History:

Over the past 52 weeks, BCRX has reached a high of $7.95, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 11.10%, while the 200-Day Moving Average is calculated to be 12.25%.

Shares Statistics:

According to the various share statistics, BCRX traded on average about 3.68M shares per day over the past 3-months and 4228040 shares per day over the past 10 days. A total of 205.77M shares are outstanding, with a floating share count of 198.07M. Insiders hold about 4.02% of the company’s shares, while institutions hold 86.59% stake in the company. Shares short for BCRX as of 1718323200 were 29671832 with a Short Ratio of 8.07, compared to 1715731200 on 34352068. Therefore, it implies a Short% of Shares Outstanding of 29671832 and a Short% of Float of 14.499999999999998.

Most Popular